Evaluation of acute toxicity and analgesic activities of Mekong Cissus capsules on experimental animals

Pham Thi Van Anh, Tran Hoang Phuong, Pham Quoc Binh, Nguyen Tien Chung, Pham Quoc Su, Pham Ngoc Cam Ly, Nguyen Thi Thuy Hang, Bui Thi Van Anh, Dinh Thi Thu Hang

Nội dung chính của bài viết

Tóm tắt

Mekong Cissus capsules, a herbal preparation primarily containing Cissus quadrangularis L., were tested for both acute toxicity and pain-relieving effects in mice. The evaluation of acute oral toxicity in Swiss mice followed the procedures outlined by the WHO and the Litchfield-Wilcoxon method. Analgesic activity was assessed using three experimental models: hot plate, Von Frey, and acetic acid-induced writhing tests. No mortality or clinical sign of acute toxicity was observed, and the maximum tolerated dose was estimated at 15000 mg/kg. In the hot plate test, Mekong Cissus capsules at 288 and 864 mg/kg/day showed a tendency to prolong latency to thermal stimuli, although the changes were not statistically significant. In the Von Frey test, the higher dose (864 mg/kg/day) significantly increased both pain threshold and latency compared with baseline and control (p < 0.05), and produced a greater effect on applied force than the lower dose (p < 0.05). In the writhing test, both doses significantly reduced acetic acid-induced writhing counts from the 5th minute onward compared with the control group.

Chi tiết bài viết

Tài liệu tham khảo

1. Liu S, Wang B, Fan S, et al. Global burden of musculoskeletal disorders and attributable factors in 204 countries and territories: a secondary analysis of the Global Burden of Disease 2019 study. BMJ Open. 2022;12(6):e062183. doi:10.1136/bmjopen-2022-062183
2. Guan SY, Zheng JX, Feng XY, et al. The impact of population ageing on musculoskeletal disorders in 204 countries and territories, 1990-2021: global burden and healthcare costs. Ann Rheum Dis. 2025. doi:10.1016/j.ard.2025.08.002
3. El-Tallawy SN, Nalamasu R, Salem GI, et al. Management of Musculoskeletal Pain: An Update with Emphasis on Chronic Musculoskeletal Pain. Pain Ther. 2021;10(1):181-209. doi:10.1007/s40122-021-00235-2
4. Moretti A, Snichelotto F, Liguori S, et al. The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs. Ther Adv Musculoskelet Dis. 2024;16:1759720X241253656. doi:10.1177/1759720X241253656
5. Ahsan A, Sahu MA. A Literature Review Assessing Whether the Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) Increases the Risk of Cardiovascular Events. Cureus. 17(9):e92361. doi:10.7759/cureus.92361
6. Paul AK, Smith CM, Rahmatullah M, et al. Opioid Analgesia and Opioid-Induced Adverse Effects: A Review. Pharmaceuticals. 2021;14(11):1091. doi:10.3390/ph14111091
7. NGUYEN D. Exploring the Potential of Vietnamese Traditional Medicinal Herbs: Trends, Challenges, and Global Market Opportunities. Int J Sci Res Manag IJSRM. 2024;12:7648-7654. doi:10.18535/ijsrm/v12i10.em10
8. Sundaran J, begum R, Vasanthi M, et al. A short review on pharmacological activity of Cissus quadrangularis. Bioinformation. 2020;16(8):579-585. doi:10.6026/97320630016579
9. Vijay P, Vijayvergia R. Analgesic, anti-inflammatory and antipyretic activity of Cissus quadrangularis. 2010.
10. Na Takuathung M, Aisara J, Sawong S, et al. The effects of Cissus quadrangularis on bone-related biomarkers in humans: a systematic review and meta-analysis. BMC Complement Med Ther. 2025;25:286. doi:10.1186/s12906-025-04995-8
11. Vietnamese Ministry of Health. Vietnamese Pharmacopeia. Fifth edition. Medical Publishing House Co., Ltd.; 2017.
12. World Health Organization. Working group on the safety and efficacy of herbal medicine. Report of regional office for the western pacific of the World Health Organization. 2013.
13. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949;96(2):99-113.
14. Ankier SI. New hot plate tests to quantify antinociceptive and narcotic antagonist activities. Eur J Pharmacol. 1974;27(1):1-4. doi:10.1016/0014-2999(74)90195-2
15. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957;111(4):409-419.
16. Koster R, Anderson W, Beer E. Acetic acid for analgesic screening. Federation Proceedings. 1959;18:412-5
17. WHO Recommended Classification of Pesticides by Hazard and Guidelines to Classification, 2019 Edition. World Health Organization; 2020.
18. Raja SN, Carr DB, Cohen M, et al. The Revised IASP definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976-1982. doi:10.1097/j.pain.0000000000001939
19. Vogel H. Analgesic, Anti-inflammatory, and Anti-pyretic Activity. In: Drug Discovery and Evaluation: Pharmacological Assays. Vol 4. 2016:1783-2024. doi:10.1007/978-3-540-70995-4_9
20. Casarrubea M, Aiello S, Santangelo A, et al. Different Representation Procedures Originated from Multivariate Temporal Pattern Analysis of the Behavioral Response to Pain in Wistar Rats Tested in a Hot-Plate under Morphine. Brain Sci. 2019;9(9):233. doi:10.3390/brainsci9090233
21. Subedi M, Bajaj S, Kumar MS, et al. An overview of tramadol and its usage in pain management and future perspective. Biomed Pharmacother. 2019;111:443-451. doi:10.1016/j.biopha.2018.12.085
22. Liu S, Crawford J, Tao F. Assessing Orofacial Pain Behaviors in Animal Models: A Review. Brain Sci. 2023;13(3):390. doi:10.3390/brainsci13030390
23. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110(5-6):255-258. doi:10.1016/s0049-3848(03)00379-7
24. Panthong A, Supraditaporn W, Kanjanapothi D, et al. Analgesic, anti-inflammatory and venotonic effects of Cissus quadrangularis Linn. J Ethnopharmacol. 2007;110(2):264-270. doi:10.1016/j.jep.2006. 09.018
25. Feigni O, Mbiantcha M, William Y, et al. Immunomodulatory, Anti-Infammatory and Antioxidant Activities of Aqueous and Ethanolic Extracts of Cissus Quadrangularis Linn. (Vitaceae) in Chronic Pain.; 2022. doi:10.21203/rs.3.rs-2199999/v1